Bryn Mawr Trust CO Grifols Sa Transaction History
Bryn Mawr Trust CO
- $5.44 Billion
- Q4 2024
A detailed history of Bryn Mawr Trust CO transactions in Grifols Sa stock. As of the latest transaction made, Bryn Mawr Trust CO holds 581 shares of GRFS stock, worth $4,636. This represents 0.0% of its overall portfolio holdings.
Number of Shares
581
Previous 581
-0.0%
Holding current value
$4,636
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GRFS
# of Institutions
169Shares Held
145MCall Options Held
166KPut Options Held
103K-
Capital World Investors Los Angeles, CA21.1MShares$169 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA20.5MShares$164 Million1.82% of portfolio
-
Permian Investment Partners, LP New York, NY16.2MShares$129 Million21.69% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.3MShares$89.8 Million3.99% of portfolio
-
Armistice Capital, LLC New York, NY10MShares$80.1 Million1.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.42B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...